Analysis of Change of Optic Nerve Sheath Diameter in in Patients Operated for Urological Reasons
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03485612 |
|
Recruitment Status :
Completed
First Posted : April 2, 2018
Last Update Posted : February 24, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Anaesthetic Complication Neurological Central Nervous System Depression | Diagnostic Test: Change of Optic Nerve Sheath Diameter |
Advantages of using ultrasound in the assessment of intracranial pressure:
simple, bedside examination, repetitive, generally available, cheap, no exposure to X-rays, no need to transport the patient to the CT laboratory
Differential diagnosis:
Widening of the size of the optic nerve sheath outside of increased intracranial pressure may occur in the following pathologies:
optic neuritis optic nerve injuries meningioma of the optic nerve arachnoid cyst around the optic nerve tumors of the cavernous sinus Blood edema may occur due to impaired blood flow. The research is to determine whether the patient's position for urological procedures is safe for the patients and whether as a result of staying in such a position there is no development of cerebral edema.
| Study Type : | Observational |
| Actual Enrollment : | 69 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Analysis of Change of Optic Nerve Sheath Diameter in in Patients Operated for Urological Reasons |
| Actual Study Start Date : | April 15, 2018 |
| Actual Primary Completion Date : | December 31, 2019 |
| Actual Study Completion Date : | December 31, 2019 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
change of the optic nerve sheath diameter
The test group will be male and female patients, aged over 18 and below 90 years of age. Each patient will be operated for urological reasons in the position for lithotomy.
|
Diagnostic Test: Change of Optic Nerve Sheath Diameter
In patients, the optic nerve sheath width (ONSD) examination will be performed twice: for the first time immediately after general anesthesia and again after surgery after placing the patient in a position on the back. |
- Optic Nerve Sheath Diameter [ Time Frame: 10 hours ]
- neurological complications [ Time Frame: 5 days ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 90 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patients undergoing urologic operation
- Adults 18 to 90 years of age
- American Society of Anesthesiologists Physical grade 1-3
Exclusion Criteria:
- Patients who did not agree to participate in the study
- Patients with ophthalmic diseases
- Patients with previous history of ophthalmic surgery
- Patients with neurological disorders
- Patients with history of head surgery due to neurological disorders
- Patients with history of disease with increased intracranial pressure
- Patients with history of disease with increased intraocular pressure
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03485612
| Poland | |
| University Hospital in Cracow | |
| Kraków, Poland, 31-501 | |
| Responsible Party: | Tomasz Skladzien, senior assistant, Jagiellonian University |
| ClinicalTrials.gov Identifier: | NCT03485612 |
| Other Study ID Numbers: |
1072.6120.30.2018 |
| First Posted: | April 2, 2018 Key Record Dates |
| Last Update Posted: | February 24, 2020 |
| Last Verified: | February 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | We are undecided on this point. |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | No |
|
Optic Nerve Sheath Diameter Urological Anaesthesia point of care USG |
|
Depression Behavioral Symptoms |

